2013 Outlook
Pharm Exec presents its annual review of the year ahead – what can “c suite” executives expect on the issues and challenges that will shape big Pharma’s performance in 2013? This informative feature contains insights from key industry leaders, regulators and other influential outside stakeholders as well as suggestions on how to position your company for success in what will prove to be another year of structural change to the standard business model.

Making Sense in Spain
Pharm Exec profiles the strategy of one of Spain’s largest diversified pharma companies, Esteve, and how it is positioning a promising R&D platform for success in the larger regional and global market.

Compliance Update
In conjunction with CBI’s annual Compliance Congress, we summarize current issues and trends in industry compliance programs designed to advance the negotiated promotion and price/reimbursement commitments required by regulators. Best practices in organizing for effective compliance is featured.